HELIUS MEDICAL TECHNOLOGIES, INC. (HSDTW)
2025-06-30 | ||||
|---|---|---|---|---|
| Total revenue | 43 | |||
| Cost of revenue | 96 | |||
| Gross (loss) profit | -53 | |||
| Selling, general and administrative expenses | 2,447 | |||
| Research and development expenses | 822 | |||
| Total operating expenses | 3,269 | |||
| Loss from operations | -3,322 | |||
| Other (expense)/income, net | -420 | |||
| Interest expense, net | -628 | |||
| Change in fair value of derivative liability | -6,028 | |||
| Foreign exchange gain (loss) | 565 | |||
| Nonoperating income, net | -6,511 | |||
| Loss before provision for income taxes | -9,833 | |||
| Provision for income taxes | - | |||
| Net loss | -9,833 | |||
| Foreign currency translation adjustments | -577 | |||
| Comprehensive loss | -10,410 | |||
| Earnings per share, basic | -79.73 | |||
| Earnings per share, diluted | -79.73 | |||
| Weighted average number of shares outstanding, basic | 123,335 | |||
| Weighted average number of shares outstanding, diluted | 123,335 | |||